ISRCTN10487159
Completed
未知
Revascularisation or medical therapy in elderly patients with acute anginal syndromes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Topic: Cardiovascular
- Sponsor
- Brighton & Sussex University Hospitals NHS Trust (UK)
- Enrollment
- 251
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33226000/ (added 11/10/2021)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 80 or over
- •2\. Non STEMI characteristic chest pain accompanied by typical ischaemic ECG changes a troponin rise
- •3\. Suitable for conservative or invasive strategy
Exclusion Criteria
- •1\. Acute STEMI
- •2\. Cardiogenic shock
- •3\. Lack of suitability for whatever clinical reason to be randomised (any condition in the opinion of the Investigator would make it unsafe or unsuitable for the patient to participate in the study)
- •4\. Platelet count \=50 x 109/mm3
- •5\. Patient life expectancy \< 1 year
- •6\. Known allergies to clopidogrel, aspirin, heparin, stainless steel, IV contrast or stent
- •7\. Drug elutant
- •8\. Recent major GI haemorrhage (within 3 months)
- •9\. Any previous cerebral bleeding episode
- •10\. Participation in another investigational drug or device study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
HYbrid-Revascularisation In Senescent Cohorts: a prospective randomised comparative trial between minimally-invasive coronary revascularisation treatment without extra-corporeal circulation (off pump coronary surgery) and combined stent-implantation versus conventionally surgical treatment in cardioplegia with the aid of extra-corporeal circulatioISRCTN53284852Martin Luther-University Halle-Wittenberg (Germany)459
Completed
Not Applicable
Revascularization in Nonagenarian Patients With Critical Lower Limb IschaemiaCritical Limb IschemiaNCT02517840Hospital Universitario Getafe53
Active, not recruiting
Not Applicable
Curative and palliative treatment of adults aged > 60 years with AML.A randomised trial by OSHO on the role of (1) early intensification {OSHO protocol} vs. common standard arm of German AML Intergroup Study, (2) allografting as consolidative immunotherapy vs. a second consolidation course in elderly patients,(3) prospective evaluation of the decision between curative and palliative treatment-intention. - AML 2004 OSHO #069Acute myelogenous leukemiaEUCTR2005-002833-10-ATGerman Competence network Acute and Chronic Leukemias” sponsored by Federal Ministry of Education a330
Recruiting
Not Applicable
Conservative or Operative Therapy in Patients With a Fragility Fracture of the PelvisPelvic FractureNCT04744350Björn-Christian Link68
Active, not recruiting
Not Applicable
Functional Assessment in Elderly MI Patients with Multivessel DiseaseMyocardial InfarctionNCT03772743Consorzio Futuro in Ricerca1,445